of sulfation in the transport and toxicity of airborne P C B s h i g h l i g h t e d t h e i s o f o r m s o f c y t o s o l i c sulfotransferases that catalyze the congener-specific formation of PCB sulfates from corresponding hydroxylated PCBs (OH-PCBs) and a microsomal sulfatase catalyzing the selective hydrolysis of PCB sulfates to OH-PCBs. The same enzymes play key roles in the transport and function of a major physiological steroid hormone, dehydroepiandrosterone (DHEA). Following the sulfation of DHEA, DHEA sulfate is released into the serum, transported through binding to serum proteins, taken up by other tissues, and then converted to DHEA through action of the microsomal steroid sulfatase. Similarly, following sulfation of OH-PCBs, PCB sulfates bind reversibly, with congener-specific affinity, to serum proteins such as human serum albumin and the thyroid hormone transport protein transthyretin. Congener-and cell-selective uptake of PCB sulfates as well as intracellular sulfatase-catalyzed hydrolysis to the corresponding OH-PCBs have also been observed. Thus, it was proposed that a dynamic interchange between OH-PCBs and PCB sulfates occurs that is analogous to the synthesis, transport, cellular uptake, and intracellular hydrolysis of DHEA sulfate. This process may provide a previously unrecognized mechanism for prolonged exposure to OH-PCBs that may have important toxicological consequences.
Professor Al Klingelhutz of the University of Iowa is studying the effects of PCBs on adipose tissue. Subcutaneous white adipose tissue is capable of becoming thermogenic in a process that is referred to as "beiging." Beiging is associated with activation of the uncoupling protein, UCP1, and is known to be important for preventing adipose hypertrophy and development of insulin resistance. PCBs accumulate in fat, and it is hypothesized that disruption of adipogenesis and adipocyte function by PCBs may be causative in the development of obesity and diabetes. Professor Klingelhutz's laboratory developed immortal human subcutaneous preadipocytes that, when differentiated, are capable of beiging. Preadipocytes that were treated with PCB126, followed by differentiation, were suppressed in their ability to activate UCP1 upon β-adrenergic stimulation with norepinephrine (NE), demonstrating a block in the beiging response. Treatment of preadipocytes with another known endogenous AhR agonist, indoxyl sulfate (IS), followed by differentiation also blocked the NEstimulated upregulation of UCP1. Knockdown of the a r y l h y d r o c a r b o n r e c e p t o r ( A h R ) c a u s e d t h e preadipocytes to be refractory to PCB126 and IS effects. The chemical AhR antagonist, CH223191, was effective at preventing the effects of PCB126 but not IS, indicating AhR ligand specificity of CH223191. Repression of NE-induced UCP1 upregulation was also observed when already-differentiated mature adipocytes were treated with PCB126 but not with IS. These results indicate that exposure of preadipocytes to endogenous (IS) or exogenous (PCB126) AhR agonists is effective at blocking them from becoming functional adipocytes that are capable of the beiging response. Mature adipocytes may have differential responses. This finding suggests a mechanism by which dioxin-like PCBs such as PCB126 could lead to disruption in energy homeostasis, potentially leading to obesity and diabetes.
Professor Pamela Lein of the University of California Davis conducted a review of the literature on the neurologic effects of PCBs and presented data from her mechanistic studies of PCB developmental neurotoxicity. She concludes that PCBs remain a significant risk to human health. A primary target of concern is the developing brain. Epidemiological studies link PCB exposures in utero or during infancy to increased risk of neuropsychiatric deficits in children. Nonclinical studies of legacy congeners found in PCB mixtures synthesized prior to the ban on PCB production suggest that nondioxin-like (NDL) congeners are predominantly responsible for the developmental neurotoxicity associated with PCB exposures. Mechanistic studies suggest that NDL PCBs alter neurodevelopment via ryanodine receptor-dependent effects on dendritic arborization. Lightly chlorinated congeners, which were not present in the industrial mixtures synthesized prior to the ban on PCB production, have emerged as contemporary environmental contaminants, but there is a paucity of data regarding their potential developmental neurotoxicity. PCB 11, a prevalent contemporary congener, is found in the serum of children and their mothers, as well as in the serum of pregnant women at increased risk for having a child diagnosed with a neurodevelopmental disorder (NDD). Recent data from the Lein laboratory demonstrates that PCB 11 modulates neuronal morphogenesis via mechanisms that are convergent with and divergent from those implicated in the developmental neurotoxicity of legacy NDL PCBs. Professor Lein's review summarizes these data and discusses their relevance to adverse neurodevelopmental outcomes in humans.
PCBs have a broad range of targets of toxicity, and even though well-studied, research on PCBs continues to provide surprises. 
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